Market Overview

Epiomic Epidemiology Report: Atopic Dermatitis Forecast In 21 Major Markets 2018-2028


Epiomic Epidemiology Report: Atopic Dermatitis Forecast In 21 Major Markets 2018-2028

PR Newswire

DUBLIN, July 25, 2018 /PRNewswire/ --

The "Epiomic Epidemiology Series: Atopic Dermatitis Forecast In 21 Major Markets 2018-2028" report has been added to's offering.

Research and Markets Logo

Atopic Dermatitis, also known as eczema, is a common disorder of the epidermis of the skin causing dryness, itchiness, red rashes, inflammation, sores and blisters. It occurs mostly in early childhood and can develop from exposure to allergens and irritants, such as dust mites, pollen, peanuts and so forth. The prognosis for most patients is improvement in symptoms, and by adulthood it may disappear altogether.

This report provides the current prevalent population for Atopic Dermatitis across 21 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Russia, Turkey, South Africa, Japan, China, South Korea, Singapore, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of severity, location and IgE levels of Atopic Dermatitis, to name a few. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from our analysis team, several of the main symptoms and co-morbidities of Atopic Dermatitis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Atopic Dermatitis include:

  • Asthma
  • Rhinitis
  • Allergies (Food- or Inhalant-related)
  • Rashes
  • Eczemic lesions

Reasons to buy

  • Able to quantify patient populations in global Atopic Dermatitis market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Atopic Dermatitis and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Atopic Dermatitis prevalent population.
  • Identify sub-populations within Atopic Dermatitis which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Atopic Dermatitis patients.

Key Topics Covered:

  1. Introduction
  2. Cause Of The Disease
  3. Risk Factors & Prevention
  4. Diagnosis Of The Disease
  5. Variation By Geography/Ethnicity
  6. Disease Prognosis & Clinical Course
  7. Key Comorbid Conditions / Features Associated With The Disease
  8. Methodology For Quantification Of Patient Numbers
  9. Top-Line Prevalence For Atopic Dermatitis
  10. Features Of Atopic Dermatitis Patients
  11. Abbreviations Used In The Report
  12. Other Services & Solutions
  13. Reports & Publications
  14. Online Epidemiology Databases
  15. Online Pharmaceutical Pricing Database
  16. References
  17. Appendix

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:

SOURCE Research and Markets

View Comments and Join the Discussion!